Skip to main content
Caplight Logo









Imagene AI

Imagene AI

Private
Tel AvivHealthcare & Life Scienceshttps://imagene-ai.com/

Last Round

Series B

Jul 1, 2025

Total Funding Raised

$44.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Imagene AI is a healthtech company that develops an AI-powered software platform for precision oncology, utilizing multimodal foundation models to analyze biopsy images for biomarker detection and clinical trial optimization.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Medical AI, Drug Discovery, Healthcare Analytics, Medical Imaging

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Foundation

Keywords

precision oncologybiomarker discoverymultimodal foundation modelshistopathology AIpatient stratificationoncology intelligencedigital pathologyclinical trial designgenomic insightsAI diagnosticsfoundation modelSaaS platformfrontier AI labcomputational pathologybiotech AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Imagene AI Comparables

Compare Imagene AI with similar companies based on industry and business-model similarity.

Imagene AI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nucleai
86%
Panakeia
86%
Aignostics
81%

Imagene AI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 1, 2025
SeedMay 2, 2022
Series AMay 2, 2022

Key People

Founding team and executive leadership

Shahar Porat

Co-Founder & CTO

Founding Team

Dean Bitan

Chief Executive Officer

Executive Team

Adv. Ram Avissar

Chief Financial Officer

Executive Team

Imagene AI Investors

Notable investors and investment history

Imagene AI investors
InvestorRounds
Blumberg CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 374% MoM, reaching 10.8K.

  • Jul 1, 2025

    $23M round led by Larry Ellison.

Imagene AI Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Imagene AI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Imagene AI's valuation, stock price, and market status.

Firmographic Details

HeadquartersTel Aviv
Employee Range38
Year Founded2020
Last FundingJul 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?